c-Rel anticorps (pSer503)
-
- Antigène Voir toutes c-Rel Anticorps
- c-Rel (REL proto-oncogene (c-Rel))
-
Épitope
- pSer503
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp c-Rel est non-conjugé
-
Application
- ELISA, Immunofluorescence (IF)
- Réactivité croisée
- Humain
- Purification
- Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
- Immunogène
- Peptide sequence around phosphorylation site of serine 503 (T-S-S(p)-D-S) derived from Human Rel.
- Isotype
- IgG
- Top Product
- Discover our top product c-Rel Anticorps primaire
-
-
- Indications d'application
- IF:1:100-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied at 1.0 mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- c-Rel (REL proto-oncogene (c-Rel))
- Autre désignation
- REL (c-Rel Produits)
- Synonymes
- anticorps C-Rel, anticorps c-Rel, anticorps NFkB, anticorps c-rel, anticorps zgc:100833, anticorps Xrel2, anticorps Xrel3, anticorps rel, anticorps rel-A, anticorps rel2, anticorps rel3, anticorps v-rel, anticorps xrel, anticorps REL proto-oncogene, NF-kB subunit, anticorps reticuloendotheliosis oncogene, anticorps RELA proto-oncogene, NF-kB subunit, anticorps v-rel avian reticuloendotheliosis viral oncogene homolog, anticorps v-rel avian reticuloendotheliosis viral oncogene homolog L homeolog, anticorps ribonuclease A family member 2 pseudogene, anticorps REL, anticorps Rel, anticorps Rela, anticorps rel, anticorps rel.L, anticorps ECRP
- Sujet
-
Background: The REL gene encodes c-Rel, a transcription factor that is a member of the Rel/NFKB family, which also includes RELA (MIM 164014), RELB (604758), NFKB1 (MIM 164011), and NFKB2 (MIM 164012). These proteins are related through a highly conserved N-terminal region termed the 'Rel domain,' which is responsible for DNA binding, dimerization, nuclear localization, and binding to the NFKB inhibitor (MIM 164008) (Belguise and Sonenshein, 2007 (PubMed 18037997)).
Baeuerle, P.A. and Henkel, T. (1994) Annu Rev Immunol 12, 141-79.
Baeuerle, P.A. and Baltimore, D. (1996) Cell 87, 13-20.
Haskill, S. et al. (1991) Cell 65, 1281-9.
Thompson, J.E. et al. (1995) Cell 80, 573-82.Aliases: Avian reticuloendotheliosis antibody, C REL antibody, C Rel protein antibody, c Rel proto oncogene protein antibody, Oncogene REL antibody, Oncogene REL avian reticuloendotheliosis antibody, Proto-oncogene c-Rel antibody, REL antibody, REL_HUMAN antibody, v rel avian reticuloendotheliosis viral oncogene homolog antibody, v rel reticuloendotheliosis viral oncogene homolog antibody, V rel reticuloendotheliosis viral oncogene homolog (avian) antibody
- UniProt
- Q04864
-